# Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

> **NCT05100069** · — · RECRUITING · sponsor: **Takeda** · enrollment: 500 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)

## Interventions

- **DRUG:** Brigatinib

## Key facts

- **NCT ID:** NCT05100069
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-01
- **Primary completion:** 2030-09-30
- **Final completion:** 2030-09-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05100069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05100069, "Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05100069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*